Back
Spero Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
SPRO
Spero Therapeutics
Last Price:
$2.49
Seasonality Move:
12.43%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRO is experiencing slight selling pressure.
Spero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.77 | Sell |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 2.09 | Buy |
200-day SMA: | 1.26 | Buy |
8-day EMA: | 2.2 | Buy |
20-day EMA: | 1.36 | Buy |
50-day EMA: | 0.67 | Buy |
200-day EMA: | 0.19 | Buy |
Spero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.72 | Buy |
Relative Strength Index (14 RSI): | 42.56 | Sell |
Chaikin Money Flow: | -333607 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.72 - 2.98) | Sell |
Bollinger Bands (100): | (0.43 - 2.39) | Buy |
Spero Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spero Therapeutics Stock
Is Spero Therapeutics Stock a Buy?
-
Spero Therapeutics share price is 2.47 while SPRO 8-day simple moving average is 2.77, which is a Sell signal.
-
The stock price of SPRO is 2.47 while Spero Therapeutics 20-day SMA is 2.86, which makes it a Sell.
-
Spero Therapeutics 50-day simple moving average is 2.09 while SPRO share price is 2.47, making it a Buy technically.
-
SPRO stock price is 2.47 and Spero Therapeutics 200-day simple moving average is 1.26, creating a Buy signal.
SPRO Technical Analysis vs Fundamental Analysis
Sell
31
Spero Therapeutics (SPRO)
is a Sell
Is Spero Therapeutics a Buy or a Sell?
-
Spero Therapeutics stock is rated a SellThe current Spero Therapeutics [SPRO] share price is $2.47. The Score for SPRO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Spero Therapeutics Stock Info
Market Cap:
138.1M
Price in USD:
2.47
Share Volume:
867.4K
Spero Therapeutics 52-Week Range
52-Week High:
3.22
52-Week Low:
0.51
Sell
31
Spero Therapeutics (SPRO)
is a Sell
Spero Therapeutics Share Price Forecast
-
What is the Spero Therapeutics stock price today?The Spero Therapeutics stock price is 2.47 USD today.
-
Will SPRO stock go up or go down?Spero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Spero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spero Therapeutics is overvalued.
Is Spero Therapeutics Stock a Buy?
-
Spero Therapeutics share price is 2.47 while SPRO 8-day exponential moving average is 2.20, which is a Buy signal.
-
The stock price of SPRO is 2.47 while Spero Therapeutics 20-day EMA is 1.36, which makes it a Buy.
-
Spero Therapeutics 50-day exponential moving average is 0.67 while SPRO share price is 2.47, making it a Buy technically.
-
SPRO stock price is 2.47 and Spero Therapeutics 200-day simple moving average is 0.19, creating a Buy signal.
Fundamental Analysis of Spero Therapeutics
Is Spero Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $1.14 per share.
Technical Analysis of Spero Therapeutics
Should I short Spero Therapeutics stock?
-
SPRO Moving Average Covergence Divergence (MACD) indicator is 0.72, suggesting Spero Therapeutics is a Buy
-
Spero Therapeutics Relative Strength Index (RSI) is 42.56, which suggest Spero Therapeutics is oversold
-
The Bollinger Bands (25) for Spero Therapeutics is (2.72 - 2.98), which suggest Spero Therapeutics is a Buy
-
The Bollinger Bands (100) for Spero Therapeutics is (0.43 - 2.39), which suggest Spero Therapeutics is a Buy
* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.